[1]
Rogalski, J.K. et al. 2022. The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders – a review. Current Problems of Psychiatry. 23, 3 (Oct. 2022), 118–127. DOI:https://doi.org/10.2478/cpp-2022-0013.